Correlation Between Protalix Biotherapeutics and Werewolf Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Werewolf Therapeutics, you can compare the effects of market volatilities on Protalix Biotherapeutics and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Werewolf Therapeutics.

Diversification Opportunities for Protalix Biotherapeutics and Werewolf Therapeutics

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Protalix and Werewolf is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Werewolf Therapeutics go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and Werewolf Therapeutics

Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 2.28 times less return on investment than Werewolf Therapeutics. But when comparing it to its historical volatility, Protalix Biotherapeutics is 1.84 times less risky than Werewolf Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Werewolf Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  205.00  in Werewolf Therapeutics on September 4, 2024 and sell it today you would lose (9.00) from holding Werewolf Therapeutics or give up 4.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Protalix Biotherapeutics  vs.  Werewolf Therapeutics

 Performance 
       Timeline  
Protalix Biotherapeutics 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Protalix Biotherapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Protalix Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Werewolf Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Werewolf Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Werewolf Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Protalix Biotherapeutics and Werewolf Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protalix Biotherapeutics and Werewolf Therapeutics

The main advantage of trading using opposite Protalix Biotherapeutics and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.
The idea behind Protalix Biotherapeutics and Werewolf Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal